Research Progress
-
Mar 02, 2012GIBH’s New Progress of Treating Non-small-cell Lung Cancer (NSCLC)Small molecular EGFR inhibitors, gefinitib and erlotinib, were approved by US Food and Drug Administration in 2002 and 2004, respectively, and have achieved significant clinical benefit for non small cell lung cancer (NSCLC) patients. Bu...
-
Jan 05, 2012Vitamin C enhances the generation of mouse and human induced pluripotent stem cellsSomatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) by defined factors. However, the low efficiency and slow kinetics of the reprogramming process have hampered progress with this technology. Prof Duanqing Pei’...
-
Jan 05, 2012Vitamin C enhances the generation of mouse and human induced pluripotent stem cellsSomatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) by defined factors. However, the low efficiency and slow kinetics of the reprogramming process have hampered progress with this technology. Prof Duanqing Pei’...
-
Dec 26, 2011Drug Discovery Pipeline End of Year MeetingFrom 8th to 9th of December 2011, DDP end of year meeting was held in Shenzhen Pattaya Hotel. The head of DDP Micky Tortorella and other senior scientists have attended the meeting together with members from all the research teams.During...
-
Dec 26, 2011Drug Discovery Pipeline End of Year MeetingFrom 8th to 9th of December 2011, DDP end of year meeting was held in Shenzhen Pattaya Hotel. The head of DDP Micky Tortorella and other senior scientists have attended the meeting together with members from all the research teams.During...
-
Dec 19, 2011GIBH has extracted two compounds showing potent anti-EV71 activityEnterovirus 71 (EV71) infections frequently manifest as hand, foot, and mouth disease (FHMD), as well as encephalitis in infants and young children. EV71 can even cause severe central nervous system disease, complications, and fatalities...